22.03.2024 14:25:20 - dpa-AFX: *GILEAD SCIENCES COMPLETES ACQUISITION OF CYMABAY THERAPEUTICS FOR ABOUT $4.3 BLN IN TOTAL EQUITY VALUE

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Gilead Sciences 885823 NASDAQ 64,155 05.06.24 21:48:17 -0,005 -0,01% 64,150 64,160 64,180 64,160

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH